PK

Philip Krause

Mesoblast Limited | Non-Executive Director
Dr Krause has a combination of scientific, regulatory, clinical, and public health experience. He is currently an independent consultant, providing strategic and regulatory advice related to biological product development. Dr Krause has a strategic advisory consulting role with Mesoblast, providing advice on regulatory strategies. He is the member of the Clinical Committee Member.

Company and Role

Company
Title
Tenure
Since
MSB
MSB
Mesoblast Limited
  • Non-Executive Director
4yrs, 6mthMar 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
MSB
MSB
Mesoblast Limited
19/08/26287,50057,5003,385,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
MSB
MSB
Mesoblast Limited
19/08/26
Issued
875,000$2.370$2,073,750Issue of options
MSB
MSB
Mesoblast Limited
01/04/25
Issued
785,000$1.935$1,518,975Issue of options
MSB
MSB
Mesoblast Limited
10/01/25
Issued
540,000$2.810$1,517,400Issue of options
MSB
MSB
Mesoblast Limited
09/07/24
Issued
985,000$1.095$1,078,575Issue of options
MSB
MSB
Mesoblast Limited
28/12/23
Buy
37,500$1.108$41,536On-market trade